methyl 2-acetamido-2,4-dideoxy-4-fluoro-β-D-glucopyranoside | 210472-05-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: methyl 2-acetamido-2,4-dideoxy-4-fluoro-β-D-glucopyranoside
• CAS: 210472-05-2
• 化学式: C₉H₁₆FNO₅
• 分子量: 237.228
• InChiKey: AGRKUQZHOWDRSR-GOFVFXDOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.45
• 重原子数：
  16.0
• 可旋转键数：
  3.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  88.02
• 氢给体数：
  3.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  乙酸酐 、 methyl 2-acetamido-2,4-dideoxy-4-fluoro-β-D-glucopyranoside 在 吡啶 作用下， 以86.8%的产率得到methyl 2-acetamido-3,6-di-O-acetyl-2,4-dideoxy-4-fluoro-β-D-glucopyranoside
  参考文献：
  名称：

  Synthesis of 4-deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-d-glucose and 2-acetamido-2-deoxy-d-galactose and their effects on cellular glycosaminoglycan biosynthesis

  摘要：

  4-Deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-galactose were synthesized and evaluated as inhibitors of hepatic glycosaminoglycan biosynthesis. 2-Acetamido-1,3,6-tri-O-acetyl-2,4-dideoxy-4-fluoro-D-glucopyranose (16) exhibited a reduction of [H-3]GlcN and [S-35]SO4 incorporation into hepatocyte cellular glycosaminoglycans to 12 and 18%, respectively, of the control cells, at 1.0 mM. Similarly, 2-acetamido-1,3,6-tri-O-acetyl-2,4-dideoxy-4-fluoro-D-gala (31) exhibited a reduction of [H-3]GlcN and [S-35]SO4 incorporation to 1 and 9%. respectively, of the control cells, at 1.0 mM. Unlike 16, 31 exhibited a reduction of [C-14]Leu incorporation into cellular protein to 57% of control cells, at 1.0 mM. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0008-6215(00)00049-5
• 作为产物：
  描述：

  methyl 2-acetamido-3,6-di-O-benzoyl-2-deoxy-β-D-glucopyranoside 在 吡啶 、 氢氧化钾 、 二乙胺基三氟化硫 、 sodium nitrite 作用下， 以 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 11.5h， 生成 methyl 2-acetamido-2,4-dideoxy-4-fluoro-β-D-glucopyranoside
  参考文献：
  名称：

  Synthesis of 4-deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-d-glucose and 2-acetamido-2-deoxy-d-galactose and their effects on cellular glycosaminoglycan biosynthesis

  摘要：

  4-Deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-galactose were synthesized and evaluated as inhibitors of hepatic glycosaminoglycan biosynthesis. 2-Acetamido-1,3,6-tri-O-acetyl-2,4-dideoxy-4-fluoro-D-glucopyranose (16) exhibited a reduction of [H-3]GlcN and [S-35]SO4 incorporation into hepatocyte cellular glycosaminoglycans to 12 and 18%, respectively, of the control cells, at 1.0 mM. Similarly, 2-acetamido-1,3,6-tri-O-acetyl-2,4-dideoxy-4-fluoro-D-gala (31) exhibited a reduction of [H-3]GlcN and [S-35]SO4 incorporation to 1 and 9%. respectively, of the control cells, at 1.0 mM. Unlike 16, 31 exhibited a reduction of [C-14]Leu incorporation into cellular protein to 57% of control cells, at 1.0 mM. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0008-6215(00)00049-5

文献信息

• Novel features of acceptor recognition by β-(1→4)-galactosyltransferase
  作者：Yasuhiro Kajihara、Hisashi Kodama、Tsuyoshi Endo、Hironobu Hashimoto

  DOI：10.1016/s0008-6215(97)10093-3

  日期：1998.1

  acceptor, substrate specificities were investigated using synthetic 2-acetamido-2-deoxy- d -glucopyranose (N-acetylglucosamine) derivatives in which the 1-, 2-, 3-, 4-, and 6-positions were systematically substituted. The hydroxyl groups at the 3-, 4-, and 6-positions were substituted by fluoride, thiol or hydrogen. For modification of the 2- position, the acetamido group was converted to ethylamino-, N-methylacetamido-

  摘要为了理解β-（1→4）-半乳糖基转移酶如何识别其糖基受体，使用合成的2-乙酰氨基-2-脱氧-d-吡喃葡萄糖（N-乙酰基葡萄糖胺）衍生物（其中1-，2为-，3-，4-和6-位被系统地取代。3-，4-和6-位的羟基被氟化物，硫醇或氢取代。为了修饰2-位，将乙酰胺基转化为乙氨基，N-甲基乙酰胺基和乙酰氧基。对于异头位置，引入了几个糖残基作为N-乙酰氨基葡糖苷的糖苷配基。使用合成的N-乙酰氨基葡糖衍生物的半乳糖转移试验表明，乙酰氨基和4-羟基对于N-乙酰氨基葡糖与β-（1→4）-半乳糖基转移酶的结合都是必不可少的。该测定还显示在6-位具有大取代的N-乙酰氨基葡糖可以被识别为受体。建议在这种情况下，大取代基的位置远离催化位点或不在酶的位置。由于2-乙酰氨基和4-羟基对于识别至关重要，因此由2、3和4位组成的一面可能面向受体结合位点。建议在这种情况下，大取代基的位置远离催化位点或不在酶的位置。由于